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Abstract
Background: The TRIM5 proteins are cellular restriction factors that prevent retroviral infection in a species-specific
manner. Multiple experiments indicate that restriction activity requires accessory host factors, including E2-enzymes.
To better understand the mechanism of restriction, we conducted yeast-two hybrid screens to identify proteins
that bind to two TRIM5 orthologues.
Results: The only cDNAs that scored on repeat testing with both TRIM5 orthologues were the proteasome subunit
PSMC2 and ubiquitin. Using co-immunoprecipitation assays, we demonstrated an interaction between TRIM5a and
PSMC2, as well as numerous other proteasome subunits. Fluorescence microscopy revealed co-localization of
proteasomes and TRIM5a cytoplasmic bodies. Forster resonance energy transfer (FRET) analysis indicated that the
interaction between TRIM5 and PSMC2 was direct. Previous imaging experiments demonstrated that, when cells
are challenged with fluorescently-labeled HIV-1 virions, restrictive TRIM5a orthologues assemble cytoplasmic bodies
around incoming virion particles. Following virus challenge, we observed localization of proteasome subunits to
rhTRIM5a cytoplasmic bodies that contained fluorescently labeled HIV-1 virions.
Conclusions: Taken together, the results presented here suggest that localization of the proteasome to TRIM5a
cytoplasmic bodies makes an important contribution to TRIM5a-mediated restriction.
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Background
The species-specific tropism of numerous retroviruses is
determined by host cell proteins, termed restriction fac-
tors, which inhibit viral replication at various stages of the
viral life cycle. Many members of the TRIM family of pro-
teins act as viral restriction factors. One well-characterized
example is the ability of TRIM5a from rhesus macaques
(rhTRIM5a) to inhibit human immunodeficiency virus
type-1 (HIV-1) [1,2]. TRIM5a contains RING, B-box,
coiled-coil, and B30.2/SPRY domains [3]. The RING
domain of TRIM5a has E3-ubiquitin ligase activity, which
is important for restriction and self-ubiquitination. When
certain residues within the RING domain are mutated,
TRIM5a loses the ability to potently restrict HIV-1 and
self-ubiquitinate, demonstrating the role of ubiquitination
during TRIM5a restriction [1]. It is well established that
the restriction requires an interaction between the viral
capsid lattice and the B30.2/SPRY domain of TRIM5a
[4-6]. Following the binding of the viral core, TRIM5a
mediates an event or series of events that result in the
abortive disassembly of the viral core in a manner that
prevents the accumulation of reverse transcription (RT)
products [2,7,8]. Proteasome inhibitors prevent TRIM5a
mediated inhibition of RT products [8,9] and abortive dis-
assembly of the viral core [10,11] without affecting the
ability of TRIM5a to inhibit retroviral infection [8,9].
Additionally, TRIM5a itself is degraded in a proteasome
dependent fashion following cytoplasmic delivery of
restriction sensitive virus [12].
However, these studies relied on pharmacological inhi-
bitors of proteasome function, which can have pleiotropic
effects on the biology of cells. Specifically, proteasome
inhibitors such as MG132 deplete the cellular pool of
ubiquitin available for cellular processes distinct from
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TRIM5a can mediate the formation of unanchored K63-
linked polyubiquitin chains during restriction, which
require free cellular ubiquitin and are thought to activate
signaling pathways in a manner independent of protea-
some activity [13]. In studies relying on proteasomal inhi-
bitors, it is difficult to discriminate between a direct role
for proteasomal degradation or an indirect depletion of
free cellular ubiquitin that perturbs the generation of
K63-linked polyubiquitin chains [13].
Here, we provide evidence for a direct connection
between TRIM5a and the proteasome machinery. The
26S proteasome is a barrel shaped, multiprotein complex
consisting of a 20S core particle (CP) and 19S regulatory
particle (RP) [14]. The 20S CP is composed of heterohep-
tameric rings, two outer a-rings and two inner b-rings,
each consisting of seven structurally similar a and b subu-
nits. The 19S RP contains a base, consisting of RPT and
RPN subunits and a regulatory lid comprised of RPN sub-
units [14]. These subunits were named in studies initially
performed using yeast derived proteins, and the vast
majority of these names have been maintained in the
nomenclature describing mammalian proteasomes. One
relevant exception important in this study is the RPT1
subunit, generally referred to as PSMC2. In this study, we
use the term PSMC2, though many studies utilize the
term RPT1 to describe the mammalian homologue of this
protein [14-16]. We observe an interaction between
TRIM5a and the proteasomal subunit PSMC2 using
yeast-two-hybrid analysis. This interaction is confirmed
using co-immunoprecipitation assays and deconvolution
microscopy showing subunits of the proteasome localizing
to TRIM5a cytoplasmic bodies. Using Forster Resonance
Energy Transfer (FRET) analysis, we show that TRIM5a
closely associates (> 5 nm separation) with proteasomal
subunits in cytoplasmic bodies. Finally, we detect the pre-
sence of proteasomal subunits in TRIM5a cytoplasmic
bodies associated with restriction sensitive virions.
Results
TRIM5a associates with PSMC2 and ubiquitin in a yeast-
two hybrid system
To identify binding proteins of TRIM5, we performed yeast
two-hybrid screens using human TRIM5a and Aotus owl
monkey TRIM5Cyp fused to lexA as baits. These baits
were screened against a human cDNA library fused to
prey. This yielded approximately 3 × 10
6 transformants for
screening. Screening for interaction-positive colonies was
performed on selective medium in order to induce the
expression of cDNAs in the library. Subsequently, colonies
were tested for b-galactosidase expression and positive
clones were subjected to DNA sequencing and BLAST
analysis. From this data, proteasomal subunit PSMC2 and
ubiquitin were identified as interacting proteins of human
TRIM5a. These hits were individually verified by repeating
the two-hybrid system using individual PSMC2 and ubiqui-
tin clones. These clones were found to interact with
huTRIM5a and aotus TRIM5Cyp (Figure 1).
TRIM5a associates with PSMC2 and other proteasomal
subunits by co-immunoprecipitation
To examine the association between TRIM5a proteins and
proteasomal subunits in human cells, 293T cells were
transfected with HA-rhTRIM5a and FLAG-PSMC2. Fol-
lowing pulldown with anti-HA antibody and blotting with
anti-FLAG antibody, we detected FLAG-PSMC2 when
HA-rhTRIM5a was present, but not when pcDNA3.1 vec-
tor control was present (Figure 2A), demonstrating an asso-
ciation between PSMC2 and rhTRIM5a. To determine if
this association was specific to PSMC2 or other subunits of
the proteasome, we, similarly, transfected HA-rhTRIM5a
with FLAG-tagged versions of the proteasomal subunits
RPT3, RPT6, and RPN8 (Figure 2B, C, D). All three subu-
nits were specifically pulled down with HA-rhTRIM5a,
indicating that rhTRIM5a associates with numerous subu-
nits of the 26S proteasome. To ensure the specificity of this
pulldown, we performed a similar pulldown with FLAG-
tagged Mixed Lineage Kinase 3 (MLK3) [17]. FLAG-MLK3
did not co-immunoprecipitate with HA-rhTRIM5a (Figure
2E). This demonstrates the specificity of this interaction
Figure 1 Ubiquitin and PSMC2 identified as interacting
proteins with huTRIM5a and TRIMCyp via yeast two-hybrid.
Yeast strain bearing pSH18-34 was transformed with the bait
plasmid pEG202-human TRIM5a or the bait plasmid pEG202-
TRIMCyp. Sequentially, a pool of pJG4-5 prey plasmids containing a
cDNA library were transfected, and screening for positive interaction
proteins was performed. Screening identified two GAL4 AD fusions
that activated gene transcription by lexA fusions to human and
Aotus TRIM5a proteins that were sequenced and submitted for
BLAST analysis.
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Page 2 of 15Figure 2 TRIM5a specifically co-immunoprecipitates with proteasome subunits. (A) Co-immunoprecipitation of PSMC2 with rhTRIM5a.
293T cells were transfected with HA-rhTRIM5a and FLAG-PSMC2 or pcDNA3.1 empty vector and FLAG-PSMC2 and subjected to
immunoprecipitation (IP) with an HA antibody followed by Western blot using indicated antibodies. (B) Co-immunoprecipitation of RPN8 with
rhTRIM5a. 293T cells were transfected with HA-rhTRIM5a and FLAG-RPN8 or pcDNA3.1 empty vector and FLAG-RPN8 and subjected to
immunoprecipitation (IP) with an HA antibody followed by Western blot using indicated antibodies. (C) Co-immunoprecipitation of RPT3 with
rhTRIM5a. 293T cells were transfected with HA-rhTRIM5a and FLAG-RPT3 or pcDNA3.1 empty vector and FLAG-RPT3 and subjected to
immunoprecipitation (IP) with an HA antibody followed by Western blot using indicated antibodies. (D) Co-immunoprecipitation of RPT6 with
rhTRIM5a. 293T cells were transfected with HA-rhTRIM5a and FLAG-RPT6 or pcDNA3.1 empty vector and FLAG-RPT6 and subjected to
immunoprecipitation (IP) with an HA antibody followed by Western blot using indicated antibodies. (E) 293T cells were transfected with HA-MLK-
3 and subjected to immunoprecipitation with an HA antibody followed by Western Blot. (F) Co-immunoprecipitation of PSMC2 with huTRIM5a.
293T cells were transfected with Myc-rhTRIM5a and FLAG-PSMC2 or pcDNA3.1 empty vector and FLAG-PSMC2 and subjected to
immunoprecipitation (IP) with a FLAG antibody followed by Western blot using indicated antibodies.
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ally, huTRIM5a-Myc was immunoprecipitated with FLAG-
PSMC2 following transfection in HEK293 cells (Figure 2F),
establishing that the association of proteasomal subunits
with TRIM5a is conserved across species.
Proteasomal subunits localize to rhTRIM5a assemblies in
cells
Next we sought to examine the localization of proteasomal
subunits in HeLa cells stably expressing YFP-rhTRIM5a
[18]. Previously, we were unable to detect the localization
of rhTRIM5a and the 20S proteasome using a polyclonal
antibody [11]. However, the results described above
prompted us to speculate that this antibody did not
accurately represent the localization of proteasomal subu-
nits by immunofluorescence. We, therefore, initiated a
more comprehensive study of proteasome localization
using a large panel of antibodies to subunits of the protea-
some. As shown in Table 1 and additional file 3, these
antibodies typically fell into two categories when utilized
for immunofluorescence: those in which a pronounced
nuclear localization of the specified subunit was observed
and those in which a pronounced nuclear localization was
not observed. Numerous reports have shown that protea-
some subunits, in addition to maintaining a noticeable and
biologically relevant cytoplasmic fraction, exhibit a pro-
nounced nuclear localization [19]. Some antibodies in the
panel examined as well as the antibody used in the
Table 1 Characterization of proteasome antibodies for immunofluorescence
Proteasome Antibodies
19S Base Catalog Number Ab Nuclear Localization Locialization with rhTRIM5a
RPT1 mouse BML-PW8825 INTERMEDIATE YES
RPT1 rabbit BML-PW8165 INTERMEDIATE YES
RPT2 rabbit BML-PW8305 NO NO
RPT3 mouse BML-PW8220 YES NO
RPT3 rabbit BML-PW8175 INTERMEDIATE YES
RPT4 mouse BML-PW8310 INTERMEDIATE NO
RPT4 rabbit BML-PW8830 NO NO
RPT5 mouse BML-PW8770 YES YES
RPT5 rabbit BML-PW8765 NO NO
RPT6 rabbit BML-PW8320 YES NO
20S Alpha
2 mouse BML-PW8105 YES YES
4 mouse BML-PW8120 YES YES
5 mouse BML-PW8125 NO NO
6 mouse BML-PW8100 YES YES
7 mouse BML-PW8110 INTERMEDIATE NO
Core rabbit BML-PW8155 YES YES
Alpha 1,2,3,5,6 & 7 mouse BML-PW8195 NO NO
20S Beta
1i (LMP2-13) rabbit BML-PW8345 NO NO
1 mouse BML-PW8140 NO NO
2 mouse BML-PW8145 NO NO
2i (MECL-1) rabbit BML-PW8350 YES NO
3 mouse BML-PW8130 INTERMEDIATE NO
4 rabbit BML-PW8890 NO NO
5i (LMP7) mouse BML-PW8845 NO NO
5i (LMP7) rabbit BML-PW8355 YES NO
5 rabbit BML-PW8895 NO NO
6 rabbit BML-PW9000 NO NO
7 mouse BML-PW8135 NO NO
Antibodies were characterized based on their localization in the nucleus. Previous reports have shown that a large pool of proteasomes are located in the
nucleus while a fraction remains in the cytoplasm thus the nuclear staining represents antibodies deemed successful for immunofluorescence.
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(Table 1), casting doubt on the utility of these antibodies
for detecting proteasomal subunits by immunofluores-
cence. In contrast, the majority of antibodies did reveal a
pronounced nuclear staining by immunofluorescence.
Therefore, we used these antibodies to determine if protea-
somal subunits localize to rhTRIM5a assemblies in
HeLa stable cell lines expressing YFP-rhTRIM5a [18].
Antibodies to numerous subunits demonstrated pro-
nounced accumulation of proteasomal subunits in these
assemblies (Figure 3). Specifically, PSMC2 could be
detected in these assemblies (Figure 3A). Antibodies to the
proteasomal subunits a2, a4, a6, and RPT5 also detected a
pronounced accumulation of these proteins in YFP-
rhTRIM5a assemblies. We also detected proteasomal sub-
units associated with YFP-rhTRIM5a cytoplasmic assem-
blies using a rabbit polyclonal antibody to the 20S core
particle of the proteasome (Figure 3A). To determine if
proteasomal subunit localization was ubiquitous or if locali-
zation was specific to a subset of rhTRIM5a cytoplasmic
assemblies, we quantified the proteasome specific immuno-
fluorescent signal associated with individual cytoplasmic
assemblies identified by automated image analysis. This
analysis revealed that the vast majority of YFP-rhTRIM5a
assemblies contained proteasomal subunits. Using an anti-
body to the 20S core, 99.6% of subunits had staining levels
above background, which was defined as the staining
observed using secondary antibodies in the absence of pri-
mary antibodies (Figure 3B). Similar results were also
observed using mouse monoclonal antibodies to PSMC2
and another base subunit RPT5 as well as a4a n da6s u b u -
nits (Figure 3B). Because of the strong degree of 20S core
staining observed in YFP-rhTRIM5a assemblies using a
rabbit polyclonal antibody, this suggests that virtually all
TRIM5a assemblies associate with proteasomes. Therefore,
we believe that alterations in the percentage of cytoplasmic
bodies containing individual proteasomal subunits we
observed using antibodies represent the ability of these
antibodies to reliably detect subunits that are likely present
in these assemblies. However, we cannot exclude the possi-
bility that individual subunits are present in more or less
abundance, as proteasomal subunit populations may condi-
tionally vary [20,21]
FRET analysis reveals a direct association between
rhTRIM5a and proteasomal subunits
To better understand the association between rhTRIM5a
and proteasomal subunits, we performed immunofluores-
cence based Forster Resonance Energy Transfer (FRET)
analysis on immunofluorescently labeled rhTRIM5a
assemblies and proteasomal subunits. For these studies,
we utilized a well-characterized HeLa cell line stably
expressing HA-rhTRIM5a [2]. As previously observed
with our YFP-rhTRIM5a cell line, proteasomal subunits
could be observed to localize to rhTRIM5a assemblies in
these cells (Additional File 1). We labeled HA-rhTRIM5a
and proteasomal subunits using secondary antibody com-
binations that have been previously used to measure
FRET interactions in cells [22]. To measure FRET, we
utilized the acceptor photobleaching approach, in which
the acceptor of a FRET pair is serially photobleached,
and the fluorescence of the donor fluorophore is mea-
sured over time [23-25]. In this system, if FRET occurs
between two fluorophores, then bleaching of the acceptor
will result in an increase in the fluorescence of the donor
fluorophore as the acceptor fluorophore becomes unable
to absorb the energy released from the donor. When
PSMC2 was labeled using Alexa546 (donor) and HA-
rhTRIM5a was labeled using Cy5 (acceptor), serial
p h o t o b l e a c h i n go fC y 5r e s u l t e di na ni n c r e a s ei nt h e
fluorescence detected for PSMC2 (Alexa546). Control
bleaching of Cy5 in cells stained with Cy5 secondary anti-
body alone, in the absence of aHA primary antibody, did
not exhibit this pattern (Figure 4A). Similar results were
obtained when a rabbit polyclonal antibody to the 20s
proteasome was used (Figure 4B). FRET measurement is
generally accepted to indicate a direct (< 5 nm) associa-
tion between two proteins. In this case, because both pri-
mary and secondary antibodies were used in this assay,
w ec a n n o td e f i n i t i v e l ys t a t et h i st ob et r u eb e c a u s et h e
addition of a secondary antibody, which has a hydrody-
namic radius of 5.5 nm [26] results in a two-fold decrease
in the resolution of this assay (> 10 nm). However, these
experiments provide evidence that TRIM5a and protea-
somal subunits exist in very close proximity in
rhTRIM5a assemblies, well below what can be observed
using colocalization analysis (Figure 3), which is limited
by the resolution limit of light microscopy (~200 nm).
To determine if these proteins were within proximity
(typically less than 5 nm) and therefore directly interact-
ing, we performed FRET analysis using fusion proteins in
which rhTRIM5a a n dP S M C 2w e r ef u s e dt ot h ec o m -
monly used FRET pair of CFP and YFP, respectively. In
live cells transfected with both CFP-rhTRIM5a and YFP-
PSMC2, colocalization of rhTRIM5a and PSMC2 could
be readily observed (Additional File 2). We then utilized
acceptor photobleaching to determine if FRET occurred
between these two proteins in areas of notable colocaliza-
tion. In this method, the acceptor (YFP-PSMC2) is seri-
ally photobleached. FRET is subsequently measured as an
increase in donor fluorescence (CFP-rhTRIM5a)w h i c h
occurs as the acceptor is bleached and therefore no
longer absorbs the resonant energy from the donor
(Additional File 2) [27]. In these experiments, notable
increases in the CFP-rhTRIM5a fluorescence were
observed following YFP-PSMC2 photobleaching but an
increase was not detected when YFP empty vector was
photobleached (Figure 5A). While the FRET difference
Lukic et al. Retrovirology 2011, 8:93
http://www.retrovirology.com/content/8/1/93
Page 5 of 15Figure 3 Proteasomal subunits localize to TRIM5a assemblies at various frequencies. (A) HeLa cells stably expressing YFP-rhTRIM5a were
fixed and immunostained with antibodies specific to the individual subunits of the proteasome. Z-stack images were collected with a
DeltaVision microscope equipped with a digital camera using a 1.4-numerical aperture (NA) 100× objective lens, and were deconvolved with
SoftWoRx deconvolution software. Individual channel images were superimposed to create the merged panels. (B) Deconvolved images were
analyzed for subunit mean fluorescence intensity (MFI) in YFP-rhTRIM5a cytoplasmic bodies by the use of the Surface Finder function in the
Imaris software (Bitplane). For each YFP-rhTRIM5a cytoplasmic body, the MFI of the subunit was determined and the data was plotted in
GraphPad Prism 5
® software.
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Page 6 of 15between YFP-PSMC2 and YFP empty vector samples was
statistically significant (p < 0.0001), there were also
numerous CFP-rhTRIM5a assemblies in which photo-
bleaching of YFP-PSMC2 did not induce an apparent
increase in CFP-rhTRIM5a fluorescence (data not
shown). This suggests that these two proteins do not
directly interact in some assemblies. Although we
attempted to focus our analysis only on assemblies that
d i dn o te n t e ro rl e a v et h ep l a n eo ff o c u sd u r i n gt h e
course of the experiment, we were concerned that the
disparate results obtained were a result of the movement
of some assemblies relative to the focal plane during the
analysis period. To address this concern, we also per-
formed E-FRET analysis on these assemblies by measur-
ing the amount of YFP fluorescence induced following
CFP excitation. Because this method allows a calculation
of FRET efficiency derived from three individual images
taken in rapid succession, movement of TRIM5a assem-
blies during the acquisition period was not a concern.
When this method of analysis was utilized, we again
observed that the FRET efficiencies of individual assem-
blies varied considerably (Figure 5B).
It is somewhat surprising that our immunofluorescence
based FRET assay consistently exhibited FRET while our
fusion protein based assay indicated significant variabil-
ity in the degree of FRET observed. However, both
methods collectively demonstrate that, in some assem-
blies, a direct interaction between rhTRIM5a and
PSMC2 exists.
Proteasomal subunits are present in rhTRIM5a assemblies
containing HIV-1 virions
The studies above examined the localization of proteaso-
mal subunits to rhTRIM5a assemblies that exist in cells in
the absence of virus. The degree to which pre-existing
rhTRIM5a cytoplasmic bodies resemble assemblies that
form around individual virions [11] is unclear. One recent
study has found that TRIM5a forms hexagonal protein
assemblies in the presence or absence of in vitro
assembled hexameric capsid structures [28], suggesting
that TRIM5a forms structurally similar assemblies in the
presence or absence of restriction sensitive virus. The ten-
dency to form such assemblies is enhanced by the pre-
sence of these hexameric capsid assemblies [29]. However,
Figure 4 TRIM5a associates with PSMC2 and 20S. (A) Cells stably expressing HA-rhTRIM5a were seeded on glass coveslips and
immunostained for HA using Cy5 rabbit antibody and endogenous proteasome subunit PSMC2 using Al546 mouse antibody. Following staining
procedure, cells were fixed and mounted on glass slides. Cy5 channel was progressively bleached and fluorescence intensity was detected over
time in Al546 and Cy5 channels. Images were analyzed using softWoRx software. (B) Cells stably expressing HA-rhTRIM5a were immunostained
for HA using Cy5 rabbit antibody and endogenous 20S core particle using Al546 mouse antibody. Cy5 channel was progressively bleached and
fluorescence intensity was detected over time in Al546 and Cy5 channels. Images were analyzed using softWoRx software.
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cytoplasmic assemblies of TRIM5a that form around a
restriction sensitive virus and those that form in the
absence of virus. We, therefore, sought to determine if
TRIM5a assemblies that form around restriction sensitive
virus also contain proteasomal subunits. To this end, we
infected a HeLa cell line stably expressing YFP-rhTRIM5a
with low levels of pre-existing cytoplasmic bodies with
VSV-g pseduotyped HIV-1 virions fluorescently labeled
with an mCherry-Vpr fusion protein [11,30]. Following
infection for 30 minutes, cells were fixed, stained for pro-
teasomal subunits and quantified for any colocalization
between rhTRIM5a formed cytoplasmic bodies, restriction
sensitive virus, and proteasomal subunits (Figure 6). As the
engagement of the viral capsid by rhTRIM5a rapidly leads
to the loss of virally associated fluorescent signal, [11],
only a small percentage of viral particles could be observed
associating with TRIM5a in fixed cell images in the
absence of proteasome inhibitor, as we have previously
reported [11]. However, when we did detect such com-
plexes, both proteasomal subunit PSMC2 and the 20S
core localized to cytoplasmic assemblies of TRIM5a that
formed around a restriction sensitive virus. When these
images were quantified, approximately 60% of TRIM5a
cytoplasmic bodies that contained virus also contained the
20S proteasome (data not shown), demonstrating that pro-
teasomal subunits are recruited to TRIM5a assemblies
which associate with HIV-1 viral complexes.
Figure 5 TRIM5a directly associates with proteasome subunit PSMC2. (A) Progressive acceptor photobleaching of YFP-PSMC2 resulted in an
increase in CFP-rhTRIM5a fluorescence indicating FRET. YFP-PSMC2 or YFP empty vector and CFP-rhTRIM5a were transfected in HeLa cells at a
1:1 ratio. Over the course of 10 minutes, 50 frames were obtained for YFP and CFP channels. (B) Fluorescence intensities of CFP-rhTRIM5a and
YFP-PSMC2 are recorded. EFRET is calculated as a relative increase of YFP fluorescence intensity (%) after photobleaching of the CFP FRET
acceptor.
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Page 8 of 15Figure 6 Proteasome associates with TRIM5a cytoplasmic bodies containing restriction sensitive virus. HeLa cells stably expressing YFP-
rhTRIM5a at low levels were seeded on glass coverslips and infected with VSVg pseudotyped HIV-1 virions containing fluorescently tagged
mCherry-Vpr for 30 minutes at 37°. Following infection, cells were fixed and stained for the endogenous (A) PSMC2 proteasomal subunits and (B)
20S core. Z-stack images were collected and deconvolved using Deltavision deconvolution software. Individual channel images are
superimposed to create the merged panels.
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Previous studies utilizing pharmacological proteasome
inhibitors have suggested a role for proteasome mediated
degradation in rhTRIM5a restriction [8,9,11,12]. However,
evidence demonstrating an actual interaction between
rhTRIM5a and the proteasome has not been published.
Due to the potential pleiotropic effects of proteasomal
inhibitors on cellular function, such as depletion of the
free cellular ubiquitin, it is possible that previously
obtained results may not represent a direct role for the
proteasome in HIV-1 restriction mediated by TRIM5a.
Indeed, recent data have described a proteasome indepen-
dent role for ubiquitin and rhTRIM5a E3- ligase activity
in retroviral restriction [13]. In this work, we utilized four
methods to demonstrate an interaction between proteaso-
mal subunits and rhTRIM5a. Yeast two-hybrid analysis of
a cDNA library containing 9.6 × 10
6 clones identified
PSMC2 as a huTRIM5a and TRIM5Cyp interacting pro-
tein. We also used co-immunoprecipitation and immuno-
fluorescence localization studies to show an association
between various proteasomal subunits, including PSMC2
and rhTRIM5a. Using FRET analysis, we show a direct
interaction between PSMC2 and rhTRIM5a in cytoplas-
mic rhTRIM5a assemblies.
Notably, the majority of studies examining the turnover
of TRIM5a have observed only a mild effect of protea-
some inhibitors on TRIM5a turnover [8,10,31,32] suggest-
ing that the turnover of TRIM5a in the absence of the
virus occurs in a manner that is predominantly protea-
some independent. We also observe that the cell lines
used in these studies show similar sensitivity to protea-
some inhibitors (data not shown). However, one study
showed that, following exposure to restriction sensitive
virus, TRIM5a degradation transitions to a proteasome
dependent mechanism [12]. However, the mechanism by
which TRIM5a becomes sensitive to proteasomal degra-
dation remains unclear. Our FRET experiments suggest a
possible explanation for this observation.
FRET analysis of the interaction between PSMC2 and
rhTRIM5a provides insight into the nature of this associa-
tion and its underlying biology. We observed an apparent
discord between our immunofluorescence based FRET
analysis and our fluorescent protein based FRET analysis.
There are two possibilities to explain this discrepancy.
First, our fluorescent protein based FRET may have
yielded variable results because FRET measurements in
this assay can be affected if the fluorescent fusion protein
does not exhibit the same full biological activity as the
native protein. While our previous studies have demon-
strated that fluorescent tags do not alter the activity of
rhTRIM5a restriction, it was not feasible to similarly char-
acterize the biological activity of our YFP-PSMC2 con-
struct, which may have contributed to some of the
variability observed in these experiments. However, it is
also possible that the differences between these assays
were due to decreased spatial stringency afforded by the
utilization of antibodies used to detect rhTRIM5a and
endogenous PSMC2 in our immunofluorescent FRET.
This decreased stringency may be due to: 1) the hydrody-
namic radius of the antibody versus the fluorescent pro-
tein size or 2) a single donor can transfer energy to
multiple acceptors in immunofluorescent FRET while the
same phenomenon does not occur in the fluorescent pro-
tein based FRET. A single antibody has a hydrodynamic
radius of 5.5 nm [33] while a fluorescent protein is 2-3 nm
in size [34]. Therefore, the use of antibodies may have
allowed FRET to occur despite the lack of direct interac-
tion between PSMC2 and rhTRIM5a in all cases. A possi-
ble explanation for the observed heterogeneity using
fluorescent protein based FRET is that another protein fre-
quently separates rhTRIM5a from the proteasome
machinery. In our previous work, we showed that p62
directly associates with rhTRIM5a using fluorescent pro-
tein FRET and that p62 siRNA knockdown increases the
turnover rate of rhTRIM5a, reducing the steady state
expression of TRIM5a [25]. We, therefore, speculate that
the differences noted in our FRET analyses indicate that
p62 may reduce the accessibility of rhTRIM5a to degrada-
tion in the absence of virus. In some assemblies, this
sequestration of rhTRIM5a by p62 may be less efficient,
allowing the proteasome machinery to engage rhTRIM5a
in these assemblies. This would be consistent with the
mild but incomplete sensitivity of TRIM5a turnover to
proteasomal inhibitors [8,10,31]
We also show that proteasomal subunits associate with
rhTRIM5a assemblies containing fluorescently labeled
HIV-1 virions. We have previously shown that the forma-
tion of rhTRIM5a assemblies around HIV-1 virions leads
to the rapid loss of virion fluorescent signal [11]. Taken
together with our imaging data presented here, showing
proteasomal subunits are present in rhTRIM5a/HIV-1
complexes, the data suggest that proteasomal subunits are
rapidly recruited to these complexes and they are impor-
tant to the restriction process mediated by TRIM5a.
Mechanistically how the proteasome is engaged during the
restriction process is not known. We detected proteasomal
subunits in a greater percentage of preexisting cytoplasmic
bodies (> 90%) (Figure 3) compared to cytoplasmic bodies
containing HIV-1 virions (~60%). The simplest explana-
tion for this observation is that proteasomal subunits are
recruited to cytoplasmic bodies which form de novo
around a restriction sensitive viral core. This would be
consistent with other studies which have found that preex-
isting cytoplasmic bodies are not required for restriction
[35,36]. The recruitment of proteasomal subunits to this
complex, sufficient to be detected by immunofluorescence,
Lukic et al. Retrovirology 2011, 8:93
http://www.retrovirology.com/content/8/1/93
Page 10 of 15would then occur. Our fixed cell imaging likely detected
complexes in various stages of this process, leading to a
reduced number of these assemblies containing detectable
amount of proteasomal subunits, compared to preexisting
cytoplasmic bodies.
Precisely how the proteasome is involved in restriction is
unclear. It is possible that the proteasome recognizes the
virus complexed with TRIM5a, leading to direct degrada-
tion of viral components. An alternative possibility is that
that the proteasome recognizes TRIM5a directly, which is
itself degraded in a manner that leads to the abortive dis-
assembly of the viral core without the direct degradation
of viral proteins. The foundation for either possibility has
been described here, in which we show a direct role for
the proteasome in rhTRIM5a-mediated restriction. In the
future, we will pursue experiments to explore either
possibility.
Conclusions
Here, we show that proteasomal subunits associate with
TRIM5a in multiple ways, and this association also
occurs while in complex with restriction sensitive HIV-1
virions. These findings suggest that association of the
proteasome with TRIM5a is relevant to TRIM5 biology
and restriction.
Materials and methods
Yeast Two Hybrid Screen
The yeast-two-hybrid screen was based on previously
described reagents and protocols [37]. Yeast strain
EGY48 (MATa trp1 his3 LEU2::pLexAop6-LEU2) bearing
pSH18-34, a reporter plasmid containing 8 lexA-binding
sites that direct transcription of lacZ, was sequentially
transformed with the bait plasmid pEG202-human-
TRIM5a, or the bait plasmid pEG202-TRIMCyp. Then
yeast was transformed with pJG4-5 (prey), > 90% of
which contain a HeLa cell cDNA library, in a pool of 9.6
×1 0
6 individual clones. After each transformation, colo-
nies were selected on synthetic drop-out medium. Trans-
f o r m a t i o ne f f i c i e n c yf o rt h ep r e yp l a s m i dw a s1 0
5
colonies per μgD N A ,a n d2 5μg of the library plasmid
pool were used to achieve a total of approximately 2-3 ×
10
6 colonies for screening. Screening for interaction-posi-
tive colonies was performed on selective, galactose-con-
taining medium in order to induce the expression of the
cDNAs in the library. Subsequently, a filter-lift assay was
used to confirm positive clones. Briefly, filters were used
to lift colonies from media plates, placed at -80°C for
15 minutes to disrupt yeast cell walls, and incubated on
Whatman paper soaked in buffer Z containing X-gal.
Colony lifts that turned blue within 30 minutes at 37°C
were termed putative positive interactors, and the corre-
sponding colonies were picked and analyzed further.
Library-cDNA containing plasmids (pJG4-5) were
recovered from positive clones. Since these clones con-
tained all three plasmids (reporter, bait, and prey), it was
necessary to make use of the KC8 E. coli strain to isolate
pJG4-5. KC8 bacteria are trp- and can be selected on
TRP- plates that only allow growth if the bacteria contain
pJG4-5 (TRP153 selection marker). The library inserts of
recovered pJG4-5 plasmids were sequenced, submitted to
BLAST analysis, and retested for activity in the two-
hybrid system as individual clones.
Recombinant DNA Constructs
HA-tagged rhTRIM5a and huTRIM5a-Myc have been
previously described [38,39]. FLAG-tagged proteasomal
subunits were generously provided by Dr. Shigeo Murata
[40]. 3X-FLAG PSMC2 was generated by PCR-amplifica-
tion of the PSMC2 open reading frame from pCMV6-AC-
PSMC2 plasmid (Origene) using primers that introduced
unique SpeI and NotI sites at the start codon and 3’ of the
stop codon, respectively. The PCR product was digested
with SpeIa n dNotI and then inserted into a customized
pcDNA3.1 (-)-3XFlag expression vector. This generated
PSMC2 was fused to an N-terminal 3X-FLAG. The insert
of the resulting pcDNA3.1 (-) 3XF-PSMC2 plasmid was
sequenced completely to confirm the presence of the wild-
type open reading frame and exclude the acquisition of
unwanted mutations during amplification. Yellow fluores-
cent protein (YFP) C1-PSMC2 was generated by PCR
amplifying PSMC2 from a FLAG-PSMC2 plasmid that
was generously provided by Dr. Shigeo Murata using the
following forward primer 5’-GCGCGAAGCTTGGATG
CCGGATT-3’ and reverse primer 5’-GCGCGTCGACT-
CATCAGTTGTATG-3’.T h eP C Rp r o d u c tw a si n s e r t e d
into YFP C1 vector (Clontech) using HindIII and SalI
(New England Biolabs) restriction sites. The YFP C1-
PSMC2 clone was confirmed with restriction digest and
sequencing analysis to confirm the presence of the wild
type open reading frame and fluorescent protein.
Cell culture, transfection and virus production
HeLa and 293T cells were cultured in complete DMEM
containing 10% fetal bovine serum, penicillin (final con-
centration 100 U/ml), and streptomycin (final concentra-
tion 100 μg/ml). mCherry-Vpr labeled virus was produced
by Polyethylenimine (PEI) transfection [41] of 293T cells
with 3.3 μgo fp V S V - G ,5μg of the proviral construct R7Δ
EnvGFP in which the Nef gene was replaced with GFP
and 1.7 ug mCherry-Vpr. Virus was harvested as pre-
viously described [42].
Stable cell lines
HeLa cells stably expressing HA-rhTRIM5a [43] or
YFP-rhTRIM5a [18] have been previously described. To
generate HeLa cells to measure cytoplasmic body forma-
tion during viral infection, cells were transduced with
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G418 (400 μg/mL) containing media. Single colony
clones were screened by immunofluorescence to identify
a cell line that expressed YFP-rhTRIM5a containing
reduced pre-existing cytoplasmic bodies in the absence
of restriction sensitive virus.
Antibodies
Antibodies to various proteasomal subunits were pur-
chased from Enzo Life Sciences (Table 1) and rabbit anti-
PSMC2 was purchased from Santa-Cruz. Monoclonal
Anti-FLAG M2-peroxidase antibody was purchased from
Sigma (Catalog Number: A8592), and Anti-HA-peroxidase
antibody was purchased from Roche (Catalog Number:
12013819001).
Co-Immunoprecipitation
Rhesus TRIM5a co-immunoprecipitation
Sub-confluent 293T cells grown in 10-cm dishes were
transfected with 10 ug of total plasmid DNA using PEI.
48-hours post transfection cells were washed with 1 ml
ice-cold phosphate buffered saline (PBS) and lysed with 1
ml ice-cold lysis buffer (50 mM Tris, pH 7.4, 125 mM
NaCl, 1% NP-40) supplemented with phosphatase inhibi-
tor cocktail (Roche). Crude cell lysates were collected,
transferred to a pre-chilled 2 ml microcentrifuge tube, and
solubilized at 4° for one hour. Following solubilization,
cells were sonicated for 10 seconds and centrifuged at
13,000- × g for 20 minutes at 4°C. 50 uL of supernatant
were aliquoted for total cell lysate, and an equal volume of
2X Laemmli sample buffer was added; samples were then
boiled for five minutes at 100°C. To pull down HA-
rhTRIM5a, anti-HA antibody (Sigma) was added to the
remaining supernatant at a 1:200 dilution and incubated at
4°C for two hours. 50 ul of protein A beads (Miltenyi Bio-
tec) were added to the supernatant and incubated at 4°C
for an additional hour. Samples were loaded on MACS
separation columns (Miltenyi Biotec), followed by three
washes with wash buffer (150 mM Tris, pH 7.4, 125 mM
NaCl, and 1% NP-40). Protein complexes were eluted in
30 uL of pre-warmed 1X sample buffer.
Human TRIM5a co-immunoprecipitation
Sub-confluent HEK293 cells grown in 10-cm dishes were
transfected with 24 μg total plasmid DNA using Lipofecta-
mine 2000 (Invitrogen), following the manufacturer’s pro-
tocol. Forty-two hours post-transfection, cells were
washed with 5 ml ice-cold PBS and lysed with 800 μli c e -
cold lysis buffer ((50 mM Tris, pH 7.5, 150 mM NaCl, 1%
Triton X-100, 1 mM EDTA 10% glycerol), supplemented
with protease inhibitor cocktail (Roche). Crude cell lysates
were collected, transferred to pre-chilled 2 ml microcentri-
fuge tubes, and centrifuged at 10,000 × g for 10 minutes.
The clarified lysate was transferred to pre-chilled
microcentrifuge tubes. To prepare antibody conjugated
beads, 2 μg of antibody (mouse anti-flag M2; Sigma
F1804) was conjugated to 50 μL of Protein G Dynabeads
®
(Invitrogen) following the manufacturer’sp r o t o c o l .T h e
beads were washed three times with 1 ml ice-cold lysis
buffer, resuspended in 50 μL lysis buffer, and added to the
clarified cell lysates. After two hours rotating at 4°C, the
bead-immune complexes were washed five times with 1
ml ice-cold lysis buffer, resuspended in 100 μLo f1×
Laemmli sample buffer, incubated at 100°C for five min.
Western Blotting
Samples were loaded into a 10% polyacrylamide gel for
SDS-polyacrylamide gel electrophoresis (SDS-PAGE).
After separation, the proteins were transferred to nitrocel-
lulose membrane (Bio-Rad) and detected by incubation
with anti-HA conjugated to Horseradish Peroxidase (HRP)
(Roche), anti-FLAG (Sigma) and anti-Myc. Secondary
antibodies conjugated to HRP (Thermo Scientific) were
used where necessary and antibody complexes were
detected using SuperSignal™ West Femto Chemillumi-
nescent Substrate (Thermo Scientific). Chemilumines-
cence was detected using the UVP EC3™ Imaging System
(UVP LLC).
Immunofluorescence
HeLa cells stably expressing YFP-rhTRIM5a were allowed
to adhere to fibronectin-treated glass coverslips and fixed
with 3.7% formaldehyde (Polysciences) in 0.1 M PIPES,
pH 6.8 [piperazine-N, N’-bis(2-ethanesulfonic acid)]
(Sigma). Monoclonal and polyclonal primary antibodies
raised against various proteasomal subunits were used
(Enzo Life Sciences, Table 1). Primary antibodies were sec-
ondarily labeled with Cy5 fluorophore-conjugated donkey
anti-mouse or anti-rabbit antibody (Jackson ImmunoRe-
search). Images were collected with a DeltaVision micro-
scope (Applied Precision) equipped with a digital camera
(CoolSNAP HQ; Photometrics), using a 1.4-numerical
aperture 100× objective lens, and were deconvolved with
SoftWoRx deconvolution software (Applied Precision).
Image Analysis
20 Z-stack images were acquired using identical acquisi-
tion parameters. Surfaces for cytoplasmic bodies in all
samples analyzed were defined by using a fluorescence
threshold (600 relative fluorescence units) for YFP-
rhTRIM5a,a n da l lY F P - r h T R I M 5 a bodies over a
volume of 0.011 μm
3 were used in the analysis. Decon-
volved images were analyzed for PSMC2, RPT5, Alpha
4, Alpha 6, and 20S mean fluorescence intensity (MFI)
in cytoplasmic bodies using the Surface Finder function
of the Imaris software package (Bitplane) and the data
was plotted in Prism (Graphpad Software Inc) for statis-
tical analysis.
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Immunofluorescent acceptor photobleaching in fixed cells
Cells stably expressing HA-rhTRIM5a [39] were seeded
on coverslips at a subconfluent density. Coverslips were
fixed with 3.7% formaldehyde (Polysciences) in 0.1 M
PIPES [piperazine-N, N’-bis(2-ethanesulfonic acid)], pH
6.8. Cells were immunostained with a rabbit anti-HA pri-
mary antibody (Sigma) and mouse anti-PSMC2 or rabbit
anti-20S primary antibodies (Enzo Life Sciences). Primary
anti-HA antibody was secondarily labeled with Cy5-conju-
gated anti-rabbit antibody (Jackson ImmunoResearch),
and proteasomal subunits were secondarily labeled with
anti-mouse or anti-rabbit Alexa546 (Invitrogen). Cy5
fluorophore was bleached for total of two minutes every
five seconds while fluorescence intensities were detected
in the Alexa546 and Cy5 channels. Using SoftWoRx soft-
ware, maximum intensities were analyzed over the course
of the experiment for Alexa546 and Cy5 and graphed in
Microsoft Excel.
Fluorescent protein acceptor photobleaching in live cells
FRET by acceptor photobleaching was performed as pre-
viously described [24]. Progressive acceptor photobleach-
ing was performed as follows: 50 images were obtained at
10-second intervals for both donor (CFP: excitation 427/
10, emission 473/30, 100 ms exposure) and acceptor (YFP:
excitation 504/12, emission 542/27, 40 ms exposure), with
a period of acceptor photobleaching (excitation 504/12)
between each acquisition. The CFP/YFP fluorescence
intensity of each cell in the field was quantified in Meta-
morph, and FRET efficiency was calculated from the CFP
initial and final fluorescence values, according to E = 1-
(Fprebleach/Fpostbleach).
Fluorescence imaging was performed with an inverted
microscope equipped with a 1.49 numerical aperture
objective, and a back-thinned CCD camera (iXon 887;
Andor Technology, Belfast, Northern Ireland). Image
acquisition and acceptor photobleaching was automated
with custom software macros in Meta-Morph (Molecular
Devices Corp., Downingtown, PA) that controlled motor-
ized excitation/emission filter wheels (Sutter Instrument
Co., Novato, CA) with filters for CFP/YFP/mCherry (Sem-
rock, Rochester NY). The progressive photobleaching pro-
tocol was as follows: 100-ms acquisition of CFP image and
40-ms acquisition of YFP image, followed by 10-s expo-
sure to YFP-selective photobleaching (504/12-nm
excitation).
E-FRET in live cells
E-FRET was performed as previously described [44].
E-FRET was calculated according to:
E=
IDA − a(IAA) − d(IDD)
IDA − a(IAA) + (G − d)(IDD)
where IDD is the intensity of fluorescence emission
detected in the donor channel (472/30 nm) with 427/10
nm excitation; IAA is the intensity of fluorescence emis-
sion detected in the acceptor channel with 542/27 nm
emission and 504/12 nm excitation; IDA is the intensity
of fluorescence emission detected in the “FRET” channel
with 542/27 nm emission and 427/10 nm excitation;
and a and d are cross-talk coefficients determined from
acceptor-only or donor-only samples, respectively. We
obtained a d value of 0.894 for CFP and a value of 0.108
for YFP. G is the ratio of the sensitized emission to the
corresponding amount of donor recovery, which
was 3.2.
Additional material
Additional file 1: TRIM5a associates with proteasome subunit
PSMC2 and 20S core particle in cells during immunofluorescence
based FRET. (A) HeLa cells stably expressing HA-rhTRIM5a were stained
for HA using a primary anti-HA antibody, followed by a secondary
antibody conjugated to Cy5 and endogenous PSMC2 using a mouse
monoclonal antibody, followed by a secondary antibody conjugated to
Alexa546. Z-stack images were collected and individual channel images
were used to create the merged panels. (B) HeLa cells stably expressing
HA-rhTRIM5a were stained for HA using an antibody conjugated to Cy5
and endogenous 20S core particle using a mouse monoclonal antibody
conjugated to Alexa546. Z-stack images were collected and individual
channel images were used to create the merged panels.
Additional file 2: YFP signal is progressively bleached during
photoacceptor FRET. (A) HeLa cells were transfected with CFP-rhTRIM5a
and YFP-PSMC2. Images were collected throughout the acquisition
process. Here we show CFP and YFP signal at the beginning (left) and at
the end of the acquisition process (right). (B) HeLa cells were transfected
with CFP-rhTRIM5a and YFP empty vector. Images were collected
throughout the acquisition process. Here we show CFP and YFP signal at
the beginning (left) and at the end (right) of the acquisition process.
Additional file 3: Subcellular localization and characterization of
proteasomal subunit antibodies using immunoflurescence. HeLa
cells seeded on glass coverslips were fixed with 3.7% Formaldehyde
(Methanol Free) in PIPES buffer (pH 6.8). Following fixation they were
stained with various antibodies to proteasome subunits and imaged
using a DeltaVision deconvolution microscope.
Abbreviations
rhTRIM5α: Rhesus macaque TRIM5α; RT: Reverse transcription; FRET: Forster
resonance energy transfer.
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